May 04, 2020 - In a short span of time, Gilead's Remdesivir has been successful in treating some coronavirus patients. But will this give a boost to the pharmaceutical giant?
May 01, 2020 - Amgen (AMGN) beats estimates for both earnings and sales. It maintains its previously-issued financial guidance for 2020.
May 01, 2020 - AMGN earnings call for the period ending March 31, 2020.
May 01, 2020 - Amgen Inc. (NASDAQ:AMGN) Q1 2020 Earnings Conference Call April 30, 2020 5:30 PM ET Company Participants Arvind Sood - Vice President of Investor Relations Bob Bradway - Chief Executive Officer Dave R
Apr 29, 2020 - Amarin's (AMRN) first-quarter results are likely to reflect strong demand for its cardiovascular drug, Vascepa.
Apr 26, 2020 - These companies are trying for coronavirus success -- but their commercialized products offer revenue no matter what.
Apr 24, 2020 - In Pfizer's (PFE) Biopharma unit, oncology sales are likely to have risen in the first quarter, while in non-oncology, Xeljanz and Eliquis alliance revenues are likely to have supported the top line.
Apr 22, 2020 - Solid sales of Roche's (RHHBY) new drugs in the first quarter more than offset the competition from biosimilars.
Apr 20, 2020 - This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?
Apr 17, 2020 - Treatment with Gilead's (GILD) experimental antiviral, remdesivir, shows rapid recoveries in fever and respiratory symptoms in COVID-19 patients in a Chicago hospital.